Is exposure in vivo cost-effective for chronic low back pain? A trial-based economic evaluation

BMC Health Services Research

Volumn 15, Issue 1, 2015, Pages

  Goossens, Marielle E J B ^a   De Kinderen, Reina J A ^a   Leeuw, Maaike ^b   De Jong, Jeroen R ^a,c   Ruijgrok, Joop ^c   Evers, Silvia M A A ^a,d   Vlaeyen, Johan W S ^a,e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Hoensbroek Rehabilitation Center   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Chronic low back pain; Costs; Economic evaluation; Exposure in vivo; QALYs

Indexed keywords

ADULT; CHRONIC PAIN; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DISABLED PERSON; ECONOMICS; EPIDEMIOLOGY; FEMALE; HEALTH STATUS INDICATOR; HUMAN; LOW BACK PAIN; MALE; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PSYCHOLOGY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL;

ADULT; CHRONIC PAIN; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; DISABLED PERSONS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; NETHERLANDS; QUALITY-ADJUSTED LIFE YEARS;

EID: 84949895184     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-015-1212-6     Document Type: Article

References (49)

1. Heijnk R, Koopmanschap MA, Polder J. International comparison of cost of illness. Bilthoven: RIVM; 2006.
2. Van Tulder MW, Koes BW, Bouter LM. A cost-of-illness study of back pain in The Netherlands. Pain. 1995;62(2):233-40.
3. Norlund A, Waddell G. Cost of back pain in some OECD countries. In: Nachemson AL, Jonsson E, editors. Neck and Back pain the Scientific Evidence of Causes, Diagnosis and Treatment edn. Philadelphia: Lippincot; 2000. p. 421-5.
4. Slobbe LCJ, Smit JM, Groen J, Poos MJJC, Kommer GJ. Cost of illness in the Netherlands 2007: Trends in health care expenditure 1999-2010. Bilthoven: RIVM; 2011.
5. Slobbe LCJ, Kommer GJ, Polder JJ. Kosten van ziekten in Nederland 2003. Zorg voor euro's. Bilthoven: RIVM; 2006.
6. Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain. 2002;18:355-65.
7. Goossens ME. Economic aspects of chronic musculoskeletal pain. In: Linton SJ, editor. New Avenues for the Prevention of chronic musculoskeletal pain and disability. Amsterdam: Elsevier; 2002.
8. Boonen A, van den Heuvel R, van Tubergen A, Goossens M, Severens JL, van der Heijde D, et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis. 2005;2005(64):396-402.
9. Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of ilness studies in the United States and internationally. Spine J. 2008;8:8-20.
10. Morley S, Eccleston C, Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy for chronic pain in adults, excluding headache. Pain. 1999;80:1-13.
11. Eccleston C, Williams A, Morley JS. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2009;15(2):CD007407.
12. Gheldof E, Crombez G, Van den Bussche E, Vinck J, Van Nieuwenhuyse A, Moens G, et al. Pain-related fear predicts disability, but not -pain severity: a path analytic approach of the fear-avoidance model. Eur J Pain. 2010;14:870-9.
13. Jensen J, Karpatschof B, Labriola M, Albertsen K. Do fear-avoidance beliefs play a role on the association between low back pain and sickness absence? A prospective cohort study among female health care workers. J Occup Environ Med. 2010;52:85-90.
14. Lohnberg J. A review of outcome studies on cognitive-behavioral therapy for reducing fear-avoidance beliefs among individuals with chronic pain. J Clin Psychol Med Settings. 2007;14:113-22.
15. Woods M, Asmundson GJ. Evaluating the efficacy of graded in vivo exposure for the treatment of fear in patients with chronic back pain: A randomized controlled trial. Pain. 2007;136:271-80.
16. Linton S, Boersma K, Jansson M, Overmeer T, Lindblom K, Vlaeyen J. A randomized controlled trial of exposure in vivo for patients with spinal pain reporting fear of work-related activities. Eur J Pain. 2007;12:722-30.
17. Vlaeyen JW, Morley S, Linton S, Boersma K, De Jong J. Pain-related fear: Exposure-based treatment for chronic pain. Seattle: IASP Press; 2012.
18. Smeets R, Vlaeyen J, Hidding A, Kesteer A, Van der Heijden G, Knottnerus JA. Physical training, graded activity with problem solving, or both? The one-year post-treatment results of a randomized controlled trial. Pain. 2007;134(3):263-76.
19. Leeuw M, Goossens M, Van Breukelen G, de Jong J, Heuts P, Smeets R, et al. Exposure in vivo versus operant graded activity in chronic low back pain patients: results of a randomized controlled trial. Pain. 2008;138(1):192-207.
20. van den Hout JH, Vlaeyen JW, Heuts PH, Zijlema JH, Wijnen JA. Secondary prevention of work-related disability in nonspecific low back pain: does problem-solving therapy help? A randomized clinical trial. Clin J Pain. 2003;19(2):87-96.
21. Meulders A, Vansteenwegen D, Vlaeyen J. The acquisition of fear of movement-related pain and associative learning: A novel pain-relevant human fear conditioning paradigm. Pain. 2011;152:2460-9.
22. Vlaeyen JWS, de Jong JR, Leeuw M, Crombez G. Fear reduction in chronic pain: graded exposure in vivo with behavioural experiments. In: Asmundson GJG, Vlaeyen JWS, Crombez G, editors. Understanding and treating fear of pain. Oxford: Oxford University Press; 2004.
23. de Peuter S, De Jong J, Crombez G, Vlaeyen J. The nature and treatment of pain-related fear in chronic musculoskeletal pain. Cognit Behav Psychother. 2009;23(1):85-103.
24. Leeuw M, Goossens M, Van Breukelen GJ, Boersma K, Vlaeyen J. Measuring perceived harmfulness of physical activities in patients with chronic low back pain: the Photograph Series of Daily Activities- Short electronic Version. J Pain. 2007;8(11):840-9.
25. Fordyce WE. Behavioral methods of chronic pain and illness. St Louis: Mosby; 1976.
26. Sanders S. Operant treatment. Back to basics. In:Turk DC, Gatchel RJ, editors. Psychological Approaches to Pain Management A practitioner's handbook. 2nd ed. New York: Guilford; 2002.
27. Miller RP, Kori SH, Todd DD. The Tampa Scale: A measure for kinesiophobia. Clin J Pain. 1991;7(1):51-2.
28. Hakkaart-van Roijen I, Tan SS, Bouwans CAM. Handleiding voor kostenonderzoek. Methoden en standaardkostenprijzen voor economische evaluaties in de gezondheidszorg. Amstelveen: College voor Zorgverzekeringen; 2010.
29. Goossens ME, van Molken MP R, Vlaeyen JW, Van der Linden SM, Kole Snijders AM, Heuts PH, et al. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol. 2000;53(7):688-95.
30. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2005.
31. Zorgverzekeringen Cv. In: CFHvhCvz, editor. Farmacotherapeutisch Kompas: medisch farmaceutische voorlichting. Amstelveen: CVZ; 2005.
32. Kopec JA, Esdaile JM, Abrahamowicz M, Abenhaim L, Wood-Dauphinee S, Lamping DL, et al. The Quebec Back Pain Disability Scale: conceptualization and development. J Clin Epidemiol. 1996;49(2):151-61.
33. Schoppink LE, Van Tulder MW, Koes BW, Beurskens SA, De Bie RA. Reliability and validity of the Dutch adaptation of the Quebec Back Pain Disability Scale. Phys Ther. 1996;76(3):268-75.
34. Kopec JA, Esdaile JM, Abrahamowicz M, Abenhaim L, Wood-Dauphinee S, Lamping DL, et al. The Quebec Back Pain Disability Scale. Measurement properties [see comments]. Spine. 1995;20(3):341-52.
35. Davidson M, Keating JL. A comparison of five low back disability questionnaires: reliability and responsiveness. Phys Ther. 2002;82(1):8-24.
36. van der Zee K, Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36: een handleiding. Groningen: Noordelijk centrum voor gezondheidsvraagstukken; 1993.
37. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271-92.
38. Dolan P. Modeling valuations for Euroqol Health States. Med Care. 1997;35(11):1095-108.
39. Briggs AH, Wonderling DE, Mooney C. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Econometr Health Econ. 1997;6:327-40.
40. Barber J, Thomson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med. 2000;19:3219-36.
41. Raad voor volksgezondheid en zorg. Zinnige en duurzame zorg. Zoetermeer: CVZ; 2006.
42. Fenwick E, O'Brien BJ, Briggs AH. Cost-effectiveness acceptability curves, facts, fallacies and frequently asked questions. Health Econ. 2004;13:405-15.
43. Walters SJ, Brazier J. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes. 2003;1:4.
44. Marra CA, Woolcott JC, Kopec JA, Shojania K, Offfer R, Brazier J, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQol and the HAQ) in rheumatoid arthritis. Soc Sci Med. 2005;60:1571-82.
45. Van Asselt A, Dirksen C, Arntz A, Severens J. The cost of borderline personality disorder. Societal cost of illness in BPD-patients. Eur Psychiatry. 2007;22(6):354-61.
46. CBS-StatLine. Gerapporteerd gebruik medische voorzieningen [reported use medical care]. 2010.
47. Drummond MF, Manca A, Sculpher MJ. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care. 2005;21(2):165-71.
48. Lin C-WC, Haas M, Maber CG, Machado LAC, Van Tulder M. Cost-effectiveness of guideline-endorsed treatments for low back pain: a systematic review. Eur Spine J. 2011;20(1024-1038):1024-38.
49. Smeets R, Severens J, Beelen S, Vlaeyen J, Knottnerus JA. More is not always better: Cost-effectiveness analysis of combined, single behavioral and single physical rehabilitation programs for chronic low back pain. Eur J Pain. 2009;12:71-81.